IDEX Corporation logo

IDEX Corporation (IEX)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
235. 55
-0.87
-0.368%
$
17.43B Market Cap
29.24 P/E Ratio
2.84% Div Yield
655,500 Volume
8.33 Eps
$ 236.42
Previous Close
Add Transaction
Day Range
233.45 239.13
Year Range
160.6 243.8
Want to track IEX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Idex (IEX) Up 2% Since Last Earnings Report?

Why Is Idex (IEX) Up 2% Since Last Earnings Report?

Idex (IEX) reported earnings 30 days ago. What's next for the stock?

Zacks | 10 months ago
IDEX Stock Exhibits Strong Prospects Despite Persisting Headwinds

IDEX Stock Exhibits Strong Prospects Despite Persisting Headwinds

IEX gains from strong FMT and HST momentum, strategic acquisitions and enhanced shareholder returns despite FSDP softness.

Zacks | 10 months ago
IDEX Corporation (IEX) Q3 2025 Earnings Call Transcript

IDEX Corporation (IEX) Q3 2025 Earnings Call Transcript

IDEX Corporation ( IEX ) Q3 2025 Earnings Call October 29, 2025 9:00 AM EDT Company Participants James Giannakouros - Vice President of Investor Relations Eric Ashleman - CEO, President & Director Akhil Mahendra - Interim CFO & VP of Corporate Development Conference Call Participants Deane Dray - RBC Capital Markets, Research Division Michael Halloran - Robert W. Baird & Co. Incorporated, Research Division Joseph Giordano - TD Cowen, Research Division Nathan Jones - Stifel, Nicolaus & Company, Incorporated, Research Division Bryan Blair - Oppenheimer & Co. Inc., Research Division Vladimir Bystricky - Citigroup Inc., Research Division Robert Jamieson - Vertical Research Partners, LLC Walter Liptak - Seaport Research Partners Brett Linzey - Mizuho Securities USA LLC, Research Division Presentation Operator Greetings, and welcome to the Third Quarter 2025 IDEX Corporation Earnings Conference Call.

Seekingalpha | 11 months ago
IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year

IDEX Q3 Earnings Surpass Estimates, Sales Increase Year Over Year

IEX's Q3 earnings and revenues top estimates, driven by strong gains in Health & Science Technologies and solid margin growth.

Zacks | 11 months ago
Idex (IEX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Idex (IEX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Idex (IEX) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 11 months ago
Idex (IEX) Beats Q3 Earnings and Revenue Estimates

Idex (IEX) Beats Q3 Earnings and Revenue Estimates

Idex (IEX) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.93 per share. This compares to earnings of $1.9 per share a year ago.

Zacks | 11 months ago
IDEX Gears Up to Post Q3 Earnings: What's in the Offing?

IDEX Gears Up to Post Q3 Earnings: What's in the Offing?

IEX is set to post Q3 results, with solid gains in Health & Science and Fire & Safety offset by Fluid & Metering softness.

Zacks | 11 months ago
Idex (IEX) Reports Next Week: Wall Street Expects Earnings Growth

Idex (IEX) Reports Next Week: Wall Street Expects Earnings Growth

Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 11 months ago
Why Is Idex (IEX) Up 1.1% Since Last Earnings Report?

Why Is Idex (IEX) Up 1.1% Since Last Earnings Report?

Idex (IEX) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Reasons Why You Should Avoid Betting on IDEX Stock Right Now

Reasons Why You Should Avoid Betting on IDEX Stock Right Now

IEX struggles with weakness in its FMT segment, rising costs and forex headwinds, lowering its stock over the past year.

Zacks | 1 year ago
IDEX: A Wonderful Business Finally Trading At A Real Undervaluation

IDEX: A Wonderful Business Finally Trading At A Real Undervaluation

IDEX remains a high-quality, wide-moat industrial business, delivering growth and cash flow even amid softer demand and macroeconomic uncertainty. The company's M&A strategy and strong customer relationships underpin resilience, with robust margins and a healthy balance sheet supporting ongoing value creation. The valuation has improved significantly, with shares now trading at a 20% discount to my DCF-derived intrinsic value.

Seekingalpha | 1 year ago
IDEX Corporation (IEX) Q2 2025 Earnings Call Transcript

IDEX Corporation (IEX) Q2 2025 Earnings Call Transcript

IDEX Corporation (NYSE:IEX ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants Akhil Mahendra - Interim CFO & VP of Corporate Development Eric D. Ashleman - CEO, President & Director Jim Giannakouros - Corporate Participant Conference Call Participants Andrew Edouard Buscaglia - BNP Paribas Exane, Research Division Brett Logan Linzey - Mizuho Securities USA LLC, Research Division Bryan Francis Blair - Oppenheimer & Co. Inc., Research Division Deane Michael Dray - RBC Capital Markets, Research Division Jeffrey Todd Sprague - Vertical Research Partners, LLC Joseph Craig Giordano - TD Cowen, Research Division Matt J.

Seekingalpha | 1 year ago
Loading...
Load More